UMB Bank’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
UMB Bank's CRL Position: Q2 2026 in Review
UMB Bank reduced its Charles River Laboratories (CRL) stake by 1.5% in Q2 2026, selling an estimated $1.78K and leaving 652 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #858.
UMB Bank first reported a position in CRL in Q4 2021 and has held it in 19 quarters since. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- UMB Bank held 652 shares of Charles River Laboratories worth $148K as of Q2 2026.
- UMB Bank sold 10 Charles River Laboratories shares in Q2 2026, an estimated $1.78K.
- Charles River Laboratories made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #858 holding.
- UMB Bank first reported a position in Charles River Laboratories in Q4 2021 and has held it in 19 quarters since.
- 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.